NOVEL THERAPEUTICS AND DIAGNOSTICS FOR ALZHEIMER'S AND OTHER NEURODEGENERATIVE DISEASES
Genentech-partnered AC Immune tees up $68M IPO to bankroll Alzheimer's R&D | Fierce Biotech
A Full Position In AC Immune To My Tax Loss Selling Basket (ACIU) | Seeking Alpha
AC Immune Gets €28M from Eli Lilly as Alzheimer's Drug Hits Phase I
AC Immune show first images from alpha-synuclein PET
Genentech, AC Immune reveal more about crenezumab failure
AC Immune - AnnualReports.com
AC Immune's Robust Pipeline focused on neurodegenerative diseases
New Vaccine Formulation Shows Promise for Alzheimer's Target | BioSpace
AC Immune picks up Phase 2-ready drug for Parkinson's in $58M deal with Affiris - MedCity News
AC Immune reports positive data from Alzheimer's disease vaccine
AC Immune – Swiss Biotech
Jabbing at Alzheimer's: AC Immune Takes Precision Approach to Vaccines
AC Immune (@AC_Immune_SA) / Twitter
AC Immune acquires Parkinson's vaccine candidate
Interested in helping find a cure for neurodegenerative diseases?
AC Immune: Dementia-Focused Swiss Biotech With A Sad History Of Failures (NASDAQ:ACIU) | Seeking Alpha
AC Immune and Roche rocked by Alzheimer's failure
Morphomer® and SupraAntigen® | AC Immune's Technology Platforms
ACI-7104 / AC Immune
AC Immune wins $500K to advance ALS diagnostic efforts | ALS News Today
AC Immune Alzheimer's Drug Reduces Cognitive Decline but Misses Functional Endpoints | BioSpace
AC Immune (@AC_Immune_SA) / Twitter
AC Immune (@AC_Immune_SA) / Twitter
